Evidence map›Paper›PMID 42390927›Full record

ArticleJCI insight2026

Early cell-autonomous and niche-mediated epithelial response to influenza infection in primary alveolar organoids.

Amber Elitz, Sharlene Fernandes, Kathleen Cs Cook, Helen I Warheit-Niemi, Barbara Zhao, Andrea Toth, Amanda L Zacharias, William J Zacharias

Abstract read
In one paragraph

Article in JCI insight, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Amber ElitzMedical Scientist Training Program.
Sharlene FernandesPerinatal Institute.
Kathleen Cs CookPerinatal Institute.
Helen I Warheit-NiemiPerinatal Institute.
Barbara ZhaoMedical Scientist Training Program.
Andrea TothMedical Scientist Training Program.
Amanda L ZachariasPerinatal Institute.
William J ZachariasPerinatal Institute.

Funding

Medical Scientist Training ProgramT32GM063483 · NIGMS · UNIVERSITY OF CINCINNATI · PI KHURANA HERSHEY, GURJIT K. · 2002 to 2022
$6.7M
Pulmonary Development and Disease Pathogenesis Training ProgramT32HL007752 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI Francis Xavier McCormack, Anne-Karina Theresia Perl · 1994 to 2026
$6.3M
Dynamic regulatory network models of human response to influenza virusU01AI150748 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI MARAZZI, IVAN, MIRALDI, EMILY · 2020 to 2024
$5.8M
Defining PRC2 complex epigenomic control in alveolar progenitor cellsR01HL166245 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI William John Zacharias · 2023 to 2026
$2.3M
Epigenetic Regulation of the Maturation and Function of Lung Epithelium by the SWI/SNF Proteins ARID1A and ARID1B.R01HL156860 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI SINNER, DEBORA, ZACHARIAS, WILLIAM JOHN · 2021 to 2025
$1.9M
Mechanistic evaluation of a novel Wnt-responsive adult alveolar epithelial progenitor population during regeneration after diffuse alveolar damageK08HL140178 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI ZACHARIAS, WILLIAM JOHN · 2018 to 2022
$815k
NHLBI NIH HHS K08 HL140178NHLBI NIH HHS R01 HL156860NHLBI NIH HHS R01 HL166245NHLBI NIH HHS T32 HL007752NIAID NIH HHS U01 AI150748NIGMS NIH HHS T32 GM063483
6 · The paper itself

Abstract

Influenza A virus (IAV) infection is a major cause of morbidity and mortality for patients worldwide. Alveolar type 2 (AT2) cells are the preferential target of IAV as part of the pathogenesis of viral pneumonia and acute respiratory distress syndrome (ARDS). Early IAV infection of alveolar cells has been challenging to model both in vitro and in vivo. To address this challenge, we used a combination of murine and human primary alveolar organoids to define methods for robust IAV infection and evaluated cell-autonomous consequences of IAV using a temporal series of multiome paired single-nucleus RNA and ATAC sequencing assays. Infected AT2 cells demonstrated conserved changes defined by early loss of surfactant secretion, decreased lipid biogenesis, a rapid burst of antiviral response, and late virus-mediated suppression. Surprisingly, uninfected AT2 cells underwent substantial transcriptional and epigenomic changes in IAV-treated cultures, leading to transition to damage-associated cell states within hours via a process driven by the inflammatory milieu of murine organoids. Together, these data provide methods for high-fidelity modeling of IAV infection in alveolar cells and defined a conserved AT2 cell response signature to IAV with implications for ARDS pathogenesis.

Indexed as

Alveolar Epithelial CellsInfluenza A virusInfluenza, HumanOrganoidsOrthomyxoviridae InfectionsAnimalsFemaleHumansMiceMice, Inbred C57BLRespiratory Distress SyndromeAdult stem cellsBioinformaticsInfectious diseaseInfluenzaPulmonology

Identifiers

PMID42390927
PMCPMC13464008

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.